| Monkeypox: An emerging global threat during the COVID-19 pandemic CC Lai, CK Hsu, MY Yen, PI Lee, WC Ko, PR Hsueh Journal of Microbiology, Immunology and Infection 55 (5), 787-794, 2022 | 90 | 2022 |
| Long COVID: An inevitable sequela of SARS-CoV-2 infection CC Lai, CK Hsu, MY Yen, PI Lee, WC Ko, PR Hsueh Journal of Microbiology, Immunology and Infection 56 (1), 1-9, 2023 | 70 | 2023 |
| Clinical efficacy and safety of Janus kinase inhibitors for COVID-19: A systematic review and meta-analysis of randomized controlled trials CY Chen, WC Chen, CK Hsu, CM Chao, CC Lai International immunopharmacology 99, 108027, 2021 | 33 | 2021 |
| Association of chronic kidney disease with mortality risk in patients with lung cancer: a nationwide Taiwan population-based cohort study YF Wei, JY Chen, HS Lee, JT Wu, CK Hsu, YC Hsu BMJ open 8 (1), e019661, 2018 | 23 | 2018 |
| Risk of lung cancer in patients with gastro-esophageal reflux disease: a population-based cohort study CK Hsu, CC Lai, K Wang, L Chen PeerJ 4, e2753, 2016 | 20 | 2016 |
| Clinical characteristics of Q fever and etiology of community-acquired pneumonia in a tropical region of southern Taiwan: a prospective observational study CH Lai, LL Chang, JN Lin, WF Chen, YF Wei, CT Chiu, JT Wu, CK Hsu, ... PLoS One 9 (7), e102808, 2014 | 19 | 2014 |
| Effect of colchicine on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trials SH Lan, CK Hsu, CC Lai, SP Chang, LC Lu, SH Hung, WT Lin Annals of Medicine 54 (1), 1956-1965, 2022 | 14 | 2022 |
| Effect of sofosbuvir-based treatment on clinical outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trials CK Hsu, CY Chen, WC Chen, CC Lai, SH Hung, WT Lin International Journal of Antimicrobial Agents 59 (3), 106545, 2022 | 14 | 2022 |
| Multisystem inflammatory syndrome in adults: Characteristics, treatment, and outcomes CC Lai, CK Hsu, SC Hsueh, MY Yen, WC Ko, PR Hsueh Journal of Medical Virology 95 (2), e28426, 2023 | 12 | 2023 |
| Clinical efficacy and safety of interferon-β–containing regimens in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials WC Chen, CK Hsu, CY Chen, CC Lai, SH Hung, WT Lin Expert Review of Anti-infective Therapy 20 (5), 741-747, 2022 | 8 | 2022 |
| The KRAS mutation is highly correlated with EGFR alterations in patients with non-small cell lung cancer MJ Yang, CK Hsu, HJ Chang, LC Yen, DA Tsao, HH Chiu, YT Huang, ... Fooyin Journal of Health Sciences 1 (2), 65-71, 2009 | 5 | 2009 |
| Inhaled ciclesonide for outpatients with COVID-19: A meta-analysis CK Hsu, CM Chao, CC Lai Journal of Microbiology, Immunology, and Infection 55 (6), 1129, 2022 | 4 | 2022 |
| The clinical efficacy and safety of mesenchymal stromal cells for patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials CY Chen, WC Chen, CK Hsu, CM Chao, CC Lai Journal of Infection and Public Health 15 (8), 896-901, 2022 | 4 | 2022 |
| Comparing novel antibiotics and carbapenems for complicated intra-abdominal infections: A systematic review and meta-analysis of randomized controlled trials TYT Chen, CK Hsu, SC Shih, TS Weng, HJ Tang, CC Lai International Journal of Antimicrobial Agents 62 (2), 106844, 2023 | 3 | 2023 |
| Clinical efficacy and safety of novel lipoglycopeptides in the treatment of acute bacterial skin and skin structure infections: a systematic review and meta-analysis of … CK Hsu, CY Chen, WC Chen, CM Chao, CC Lai Expert Review of Anti-infective Therapy 20 (3), 435-444, 2022 | 3 | 2022 |
| Comment on Pietropaolo et al. Incidence of an insulin-requiring hyperglycemic syndrome in SARS-CoV-2–infected young individuals: is it type 1 diabetes? Diabetes 2022; 71: 2656–2663 CK Hsu, CC Lai Diabetes 71 (12), e18-e18, 2022 | 2 | 2022 |
| Effect of Tiotropium Soft Mist Inhalers on Dynamic Changes in Lung Mechanics of Patients with Chronic Obstructive Pulmonary Disease Receiving Mechanical Ventilation: A … PK Fu, YF Wei, CC Sheu, CY Wang, CK Hsu, CM Chen, WC Chen, ... Pharmaceutics 13 (1), 51, 2020 | 2 | 2020 |
| Comparative outcomes of SARS-CoV-2 primary and reinfection in older adult patients SF Tey, YW Tsai, JY Wu, TH Liu, MH Chuang, WH Hsu, PY Huang, ... Frontiers in Public Health 12, 1337646, 2024 | 1 | 2024 |
| Clinical efficacy and safety of interleukin-1 blockade in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials SH Lan, CK Hsu, SP Chang, LC Lu, CC Lai Annals of Medicine 55 (1), 2208872, 2023 | 1 | 2023 |
| Ceftobiprole medocaril for the treatment of pneumonia WH Hsu, CK Hsu, CC Lai Expert Review of Anti-infective Therapy 21 (6), 551-563, 2023 | 1 | 2023 |
